BioSpace News Archive

May 10, 2018 12:05 UTC Motus GI to Present Data at Digestive Disease Week® 2018 Showing Pure-Vu® System May Reduce Costs and Incidence of Colorectal Cancer FORT LAUDERDALE, Fla.--( BUSINESS WIRE )-- Motus GI Holdings, Inc. , (NASDAQ:MOTS) (“Motus GI” or the “Company”), a medical technology company dedicated to improving endoscopy outcomes and experiences, announced today that data related to the Company’s Pure-Vu® System will

ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced the opening of its new subsidiary in Netherlands to support the company’s expansion into key European markets and provide on-the-ground sales and customer support for current clients, prospects and partners in the region.

Twenty abstracts including eight oral presentations to showcase Jazz’s breadth and depth of sleep medicine innovation [10-May-2018] Jazz Pharmaceuticals to Highlight Breadth of Research in Narcolepsy and Excessive Sleepiness in Obstructive Sleep Apnea at SLEEP 2018 Annual Meeting Twenty abstracts including eight oral pre

Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer will participate in a fireside chat at the Bank of America Merrill Lynch 2018 Healthcare Conference on Thursday, May 17, 2018, at 10:40 a.m. PT. The conference will be held May 15 - 17 at the Encore Wynn in Las Vegas.

Recent Evidence Shows Potential Positive Impact of Implant Design on Functional Outcomes and Hospital Discharge Status [10-May-2018] ATTUNE Knee System Linked to Improvements in Patient Quality of Life and Reduced Length of Hospital Stay Recent Evidence Shows

Engine Biosciences (“Engine”), the technology company pioneering its platform integrating big data, computation, and experimental biology to unleash faster and more effective drug discovery, today announced it has hired Stephen Harrison, Ph.D. as Chief Scientific Officer and Senior Vice President.

First-ever CT system cleared by the FDA for enhanced intraoperative margin assessment of biopsies and lumpectomies.

AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that in late 2017 it entered into a commercial supply agreement with MacroGenics, a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, for the manufacture of margetuximab, a clinical-stage, novel immune-optimized monoclonal antibody.

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present at the upcoming UBS Global Healthcare Conference taking place May 21-23, 2018 in New York, NY, USA.

Anthem, Inc. (NYSE:ANTM) announced today that Deepti Jain will lead IngenioRx